Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging

QR Code

Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging

We compared the performance of computed tomography (CT) and magnetic resonance imaging (MRI) for preoperative clinical staging of mass‐forming intrahepatic cholangiocarcinoma (iCCA), using the eighth American Joint Committee on Cancer (AJCC) system. This retrospective, multicenter, cohort study cons...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yeun‐Yoon Kim, Suk‐Keu Yeom, Hyejung Shin, Sang Hyun Choi, Hyungjin Rhee, Ji Hoon Park, Eun‐Suk Cho, Sumi Park, Seung Soo Lee, Mi‐Suk Park
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	Diseases of the digestive system. Gastroenterology RC799-869
Accès en ligne:	https://doaj.org/article/bebf443a7faf4d6286377d80bd149db6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
par: Serifis N, et autres
Publié: (2021)

Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
par: Jinqing Wu, et autres
Publié: (2021)

Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases
par: Manrong Liu, et autres
Publié: (2021)

Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions
par: Mehrotra S, et autres
Publié: (2020)

Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
par: Gunaydin M, et autres
Publié: (2018)

Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population
par: Alsaleh M, et autres
Publié: (2019)

In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils
par: Khuntikeo N, et autres
Publié: (2020)

Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis
par: Enrique Rodríguez de Santiago, et autres
Publié: (2021)

Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
par: Nicole C Steiger-Luther, et autres
Publié: (2010)

RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes
par: Hyeon‐Ji Kim, et autres
Publié: (2021)

Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping
par: Khuntikeo N, et autres
Publié: (2020)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
par: Mohammad Shehab, et autres
Publié: (2021)

Impact of early cholecystectomy on the readmission rate in patients with acute gallstone cholangitis: a retrospective single-centre study
par: Bishnu Sapkota, et autres
Publié: (2021)

Integrated real-time imaging system, ‘IRIS’, Kangaroo feeding tube: a guide to placement and image interpretation
par: Stephen Taylor, et autres
Publié: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
par: Peter M Irving, et autres
Publié: (2021)

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
par: Espul C, et autres
Publié: (2012)

Stopping anti-TNF in CD remitters: pros and cons
par: Edouard Louis
Publié: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
par: Kaleb Bogale, et autres
Publié: (2021)

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
par: Yoshimitsu K
Publié: (2014)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
par: Suad Abdeen, et autres
Publié: (2011)

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
par: Chua DL, et autres
Publié: (2014)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
par: Lim TR
Publié: (2014)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
par: Christine Beran, et autres
Publié: (2021)

Impact of Diagnostic Delay on Disease Course in Pediatric Versus Adult-onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
par: Alain M. Schoepfer, et autres
Publié: (2021)

Update on entecavir in the management of severe forms of Hepatitis B
par: Sacco R
Publié: (2012)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
par: Jinming Wang, et autres
Publié: (2021)

CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center
par: Hossein Karim, et autres
Publié: (2020)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
par: Bryan Adrian Priego-Parra, et autres
Publié: (2021)

Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
par: Shinya Sugimoto, MD, PhD, et autres
Publié: (2022)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
par: Jordi Guiu, PhD, et autres
Publié: (2022)

CMGH: The year in review
par: Klaus H. Kaestner, PhD, MS, et autres
Publié: (2021)

Contents
Publié: (2021)

Form Follows Function for Local Immune Responses in Pancreatic Cancer
par: Anna L. Means, PhD
Publié: (2021)

Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
par: Samantha B. Kemp, et autres
Publié: (2021)

Cover 2 - Tertiary Lymphoid Structures: Hub for Pancreatic Cancer Immune Response
Publié: (2021)

An Epigenetic Switch Between Differentiation and Proliferation in Hepatoblastoma
par: Jeffrey H. Albrecht, MD
Publié: (2021)

Editorial Board
Publié: (2021)

Rebuttal to: In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
par: Shinya Sugimoto, MD, PhD, et autres
Publié: (2022)

In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
par: Jordi Guiu, PhD, et autres
Publié: (2022)

Elsewhere in the AGA Journals
Publié: (2021)